logo

For the Inventor, By the Inventor

Upper Montclair, NJ, United States of America

Anil K Saksena

This inventor holds 61 USPTO granted patents and 1 published patent application and 4 EPO patents, primarily in Hepatitis C Inhibitors (CPC class 5443). Top assignees: Schering Corporation, Dendreon Corporation, Schering-Plough Corporation. Active years: 1978-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Anil K Saksena. Retrieved from https://idiyas.com/inventor/anil-k-saksena

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 61 

% Patents Active = 77.0


Average Co-Inventor Count = 5.6

ph-index = 15

Forward Citations = 752(Granted Patents)

Forward Citations (Not Self Cited) = 720(Dec 10, 2025)


Inventors with similar research interests:


Company Filing History:

goldMedal59 out of 1,829 
 
Schering Corporation
 patents
silverMedal5 out of 53 
 
Dendreon Corporation
 patents
bronzeMedal1 out of 28 
 
Schering-Plough Corporation
 patents
4. 1 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1978-2012

Loading Chart...
Loading Chart...
Areas of Expertise:
Hepatitis C Virus
NS3 Protease
Serine Protease
17β-Hydroxysteroid Dehydrogenase
Peptides
Inhibitors
Ribavirin
Farnesyl Protein Transferase
Antifungal Agents
Oligosaccharide Antibiotics
Combination Therapy
Compounds
61 patents (USPTO):Explore Patents
1. RE43298 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2012-04-02),
2. 8067379 - Sulfur compounds as inhibitors of hepatitis C virus NS3 serine protease (2011-11-29),
3. 7595299 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2009-09-29),
4. 7485645 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases (2009-02-03),
5. 7432268 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases (2008-10-07),
6. 7425576 - Compounds as inhibitors of hepatitis C virus NS3 serine protease (2008-09-16),
7. 7423058 - Inhibitors of hepatitis C virus NS3 protease (2008-09-09),
8. 7271175 - 17β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases (2007-09-18),
9. 7244721 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2007-07-17),
10. 7205330 - Inhibitors of hepatitis C virus NS3 protease (2007-04-17),
11. 7186747 - Compounds as inhibitors of hepatitis C virus NS3 serine protease (2007-03-06),
12. 7169760 - Peptides as NS3-serine protease inhibitors of hepatitis C virus (2007-01-30),
13. 7138396 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases (2006-11-21),
14. 7115578 - Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection (2006-10-03),
15. 7053091 - 17 β-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases (2006-05-30),

Title: Anil K Saksena: A Visionary Inventor in the Field of Biomedical Innovations

Introduction:

Anil K Saksena, a distinguished inventor based in Upper Montclair, NJ (US), has carved a niche for himself in the industry with his relentless passion for innovation. With an impressive portfolio of 61 patents, his groundbreaking contributions have positioned him as a visionary in the field of biomedical research.

Latest Patents:

Anil K Saksena's recent patents showcase his pioneering work in developing novel compounds for inhibiting the NS3-serine protease of the hepatitis C virus. These patents highlight his commitment to advancing scientific research and addressing critical medical challenges. The pharmaceutical compositions derived from his inventions have the potential to revolutionize the treatment of disorders associated with the HCV protease.

Career Highlights:

Throughout his illustrious career, Anil K Saksena has made significant contributions to renowned companies such as Schering Corporation and Dendreon Corporation. His innovative mindset and expertise have played a pivotal role in shaping the industry's landscape and driving advancements in biomedical technology.

Collaborations:

Anil K Saksena has collaborated with esteemed professionals in the field, including Viyyoor Moopil Girijavallabhan and Ashit K Ganguly. These partnerships have led to groundbreaking discoveries and paved the way for future innovations in the realm of biomedical research.

Conclusion:

In conclusion, Anil K Saksena's unwavering dedication to innovation and his unparalleled contributions to the field of biomedical research underscore his status as a visionary inventor. His pioneering work not only inspires future generations of inventors and innovators but also demonstrates the transformative power of ingenuity in addressing complex medical challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…